Osteoarthritis and Bone Disorders News

Patients with persistent midfoot pain, but no radiological evidence of osteoarthritis, might have under-recognized disease in the second and third cuneiform metatarsal joints, according to data published in Arthritis Care and Research.

Childhood leukemia survival outcomes in patients with musculoskeletal involvement are similar to those among patients without musculoskeletal disease, according to data published in Pediatric Rheumatology.

Although telehealth can be useful in treating patients with rheumatic diseases, diagnoses should be established in face-to-face visits, according to new EULAR points to consider.

Romosozumab improved bone mineral density at the lumbar spine, total hip and femoral neck, and reduced the relative risk for fractures in women with osteoporosis and mild-to-moderate chronic kidney disease, according to study data.

Walking for exercise appears to reduce pain progression in patients aged 50 years or older with knee osteoarthritis, according to data published in Arthritis & Rheumatology.

Patients with autoimmune rheumatic diseases who are undergoing elective hip or knee arthroplasty should maintain their usual doses of methotrexate, leflunomide, hydroxychloroquine, sulfasalazine and apremilast , according to new guidelines.

Women with polycystic ovary syndrome were more likely to have myriad medical conditions, use medications more often and report poorer health than women who did not have the disorder, according to a population-based Finnish study.

In a cohort of women, NSAID use significantly decreased the efficacy of the bisphosphonate clodronate for preventing bone loss and fractures, according to findings from a post hoc analysis.

There is a “direct correlation” between microscopic particles found in air pollution and increased incidence of osteoporosis and autoimmune disease in a cohort of individuals in Italy, according to a presenter at the EULAR 2022 Congress.

Patients with knee osteoarthritis receiving antihistamines demonstrate less structural disease progression, compared with those who did not take antihistamines, over 2 years, according to data presented at the EULAR 2022 Congress.